• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MIO; UNO INSET II 80/9 PCC GREY MIMX

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MIO; UNO INSET II 80/9 PCC GREY MIMX Back to Search Results
Model Number MMT-975
Medical Device Problem Code Detachment of Device or Device Component (2907)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Malfunction
Event or Problem Description
Unomedical reference number: (b)(4).Event occurred in (b)(6).It was reported that the patient's infusion set's tubing had detached close to site location.The site location was patient's upper thigh and the pump was on the hip area.The infusion has been used for one day.Reportedly, the infusions were stored in a carry case.There was no stress or pull on the tubing and the pump was not dropped with the set connected to the patient's body.No further information available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MIO
Common Device Name
UNO INSET II 80/9 PCC GREY MIMX
MDR Report Key11548440
Report Number3003442380-2021-00182
Device Sequence Number11719972
Product Code FPA
UDI-Device Identifier05705244007833
UDI-Public05705244007833
Combination Product (Y/N)Y
PMA/510(K) Number
K160648
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source distributor
Initial Reporter Occupation Other
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device No Information
Device Expiration Date02/01/2023
Device Model NumberMMT-975
Device Lot Number5308867
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/12/2021
Initial Report FDA Received Date03/23/2021
Patient Sequence Number1
-
-